{"id":27535,"date":"2022-12-01T03:53:21","date_gmt":"2022-12-01T04:53:21","guid":{"rendered":"https:\/\/peymantaeidi.net\/stem-cell\/?p=27535"},"modified":"2022-12-01T05:35:10","modified_gmt":"2022-12-01T05:35:10","slug":"european-biosimilar-market-to-reach-us-25446-million-by-2027-industry-cagr-of-22-8","status":"publish","type":"post","link":"https:\/\/peymantaeidi.net\/stem-cell\/2022\/12\/01\/european-biosimilar-market-to-reach-us-25446-million-by-2027-industry-cagr-of-22-8\/","title":{"rendered":"European Biosimilar Market to Reach US$ 25,446 Million by 2027 | Industry CAGR of 22.8%"},"content":{"rendered":"<div><img decoding=\"async\" src=\"https:\/\/peymantaeidi.net\/stem-cell\/wp-content\/uploads\/2022\/12\/biosimilars-market-in-europe-r.jpeg\" class=\"ff-og-image-inserted\" alt=\"image\" \/><\/div>\n<p>    European Biosimilar Market to Reach US$ 25,446 Million by 2027 | Industry CAGR of 22.8% &#8211; Nanotechnology News Today &#8211; EIN Presswire<\/p>\n<header>\n<div class=\"eh-ribbon\">\n<p>\n          Trusted News Since 1995\n        <\/p>\n<p>        <span class=\"prof not-if-mobile-w820\">A service for nanotechnology industry professionals<\/span><br \/>\n        <span class=\"not-if-mobile-w820\">\u00b7<\/span><br \/>\n        <span class=\"date\">Thursday, December 1, 2022<\/span><br \/>\n        <span class=\"not-if-mobile-w430\"><br \/>\n          \u00b7<br \/>\n          <a class=\"article_live_counter\" href=\"https:\/\/nanotech.einnews.com\/live_feed\">604,130,074<\/a><br \/>\n          Articles<br \/>\n        <\/span><br \/>\n        <span class=\"not-if-mobile-w550\"><br \/>\n          \u00b7<br \/>\n          3+ Million Readers<br \/>\n        <\/span>\n      <\/div>\n<\/header>\n<footer>\n<div class=\"sitemap\">\n<h2 class=\"subheading-osc g_roboto\">News Monitoring and Press Release Distribution Tools<\/h2>\n<div class=\"row-fluid\">\n<div class=\"span3\">\n<section>\n<h3>News Topics<\/h3>\n<\/section>\n<section>\n<h3>Newsletters<\/h3>\n<\/section><\/div>\n<div class=\"span3\">\n<section>\n<h3>Press Releases<\/h3>\n<\/section>\n<section>\n<h3>Events &amp; Conferences<\/h3>\n<\/section><\/div>\n<div class=\"span3\">\n<section>\n<h3>RSS Feeds<\/h3>\n<\/section>\n<section>\n<h3>Other Services<\/h3>\n<\/section><\/div>\n<div class=\"span3\">\n<section>\n<h3>Questions?<\/h3>\n<\/section>\n<p><\/p>\n<section>\n<\/section><\/div>\n<\/p><\/div>\n<\/p><\/div>\n<\/footer>\n","protected":false},"excerpt":{"rendered":"<p>European Biosimilar Market to Reach US$ 25,446 Million by 2027 | Industry CAGR of 22.8%<\/p>\n","protected":false},"author":1,"featured_media":27537,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/peymantaeidi.net\/stem-cell\/wp-json\/wp\/v2\/posts\/27535"}],"collection":[{"href":"https:\/\/peymantaeidi.net\/stem-cell\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/peymantaeidi.net\/stem-cell\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/peymantaeidi.net\/stem-cell\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/peymantaeidi.net\/stem-cell\/wp-json\/wp\/v2\/comments?post=27535"}],"version-history":[{"count":2,"href":"https:\/\/peymantaeidi.net\/stem-cell\/wp-json\/wp\/v2\/posts\/27535\/revisions"}],"predecessor-version":[{"id":27538,"href":"https:\/\/peymantaeidi.net\/stem-cell\/wp-json\/wp\/v2\/posts\/27535\/revisions\/27538"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/peymantaeidi.net\/stem-cell\/wp-json\/wp\/v2\/media\/27537"}],"wp:attachment":[{"href":"https:\/\/peymantaeidi.net\/stem-cell\/wp-json\/wp\/v2\/media?parent=27535"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/peymantaeidi.net\/stem-cell\/wp-json\/wp\/v2\/categories?post=27535"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/peymantaeidi.net\/stem-cell\/wp-json\/wp\/v2\/tags?post=27535"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}